Agco (AGCO) was upgraded to buy at Deutsche Bank. $68 price target. The company offers mid-cycle earnings upside potential, Deutsche said.
AthenaHealth (ATHN) was upgraded to overweight at Pacific Crest. $140 price target. Expect 2017 to be an inflection year for the company, Pac Crest said.
Hologic (HOLX) was upgraded to overweight from neutral at Piper Jaffray. $48 price target. Growth should accelerate heading into 2018, Piper said.
Navient (NAVI) was downgraded to neutral from outperform at Credit Suisse. $18 price target. Interest rate margin could compress, Credit Suisse said.
Oshkosh (OSK) was downgraded to hold at Deutsche Bank. $71 price target. The valuation is less attractive, as the stock was up 69% in 2016, Deutsche said.
Patterson-UTI (PTEN) was upgraded to overweight from sector weight at Keybanc. $35 price target. The valuation is more attractive, as the SVNT deal makes both financial and strategic sense, Keybanc said.